Genentech Parent: Roche

Genentech is a biotechnology corporation which became a subsidiary of Roche in 2009. Today, Genentech Research and Early Development operates as an independent center within Roche. Founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer, Genentech was a pioneering research-driven biotechnology company has continued to conduct R&D internally as well as through collaborations. In the digital health space, Genentech did most of its work in recent years. For instance in October 2014, it paid $150 million upfront to collaborate with Iowa-based NewLink Genetics on checkpoint inhibitors. Then in June 2015, the company entered into a wide-ranging partnership with The Data Incubator to help train and hire the next generation of data scientists at the company. And in January 2015, Genentech signed a $60 million deal with 23andMe that gave it access to the genomic and patient-reported data held by 23andMe. The Economist rated Genentech as the Most Innovative Corporation of 2013. Also on multiple occasions, it was selected as one of the top companies to work for.